Oric Pharmaceuticals ORIC 深 沪
已收盘 09-20 16:00:00 美东时间
11.25
+0.090
+0.81%
华盛通- 最 高11.70
- 今 开11.16
- 成交量 174.40万股
- 最 低 10.77
- 昨 收 11.16
- 总市值 6.14亿
- 52周最高 16.65
- 市盈率 静 --
- 换手率 3.20%
- 52周最低 5.27
- 委 比 -72.22%
- 总股本 5455.13万
- 历史最高 40.81
- 量 比 2.32
- 振 幅 8.33%
- 历史最低 2.36
- 每 手 1
- 风险率 2.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cantor Fitzgerald Reiterates Overweight on ORIC Pharmaceuticals
Cantor Fitzgerald analyst Prakhar Agrawal reiterates ORIC Pharmaceuticals (NASDAQ:ORIC) with a Overweight.
09-10 01:19
想象、身份和资本主义：日本流行音乐简史②——新式媒体之下的新音乐和偶像
日本流行音乐通常被称为J-POP， 事实上，J-POP的“J”不一定指作为国家的日本，而是指与当代日本生活方式和文化相关的概念。这种生活方式（或对这种生活方式的...
09-08 16:18
ORIC Pharmaceuticals GAAP EPS of -$0.45
ORIC Pharmaceuticals press release (NASDAQ:ORIC): Q2 GAAP EPS of -$0.45. Spectral AI GAAP EPS of -$0.16 misses by $0.01, revenue of $7.5M beats by $1.12M More on ORIC Pharmaceuticals ORIC Pharmaceutic...
08-13 04:54
快讯 | oric pharmaceuticals第二季度营业费用3601.7万美元
Oric Pharmaceuticals Q2 Operating Expenses USD 36.017 Million
08-13 04:05
快讯 | oric pharmaceuticals报告2024年第二季度财务业绩和运营更新
Oric Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operatio...
08-13 04:05
快讯 | oric pharmaceuticals第二季度净利润美元指数-3196.3万
Oric Pharmaceuticals Q2 Net Income USD -31.963 Million
08-13 04:05
快讯 | oric pharmaceuticals第二季度营业收入美元指数为-3601.7万
Oric Pharmaceuticals Q2 Income From Operations USD -36.017 Million
08-13 04:05
快讯 | Oric Pharmaceuticals第二季度基本EPS每股收益-0.45美元，预估IBES每股收益-0.41美元。
Oric Pharmaceuticals Q2 Basic EPS USD -0.45 Vs. IBES Estimate USD -0.41
08-13 04:05
快讯 | oric pharmaceuticals任命Keith Lui为商业和医疗事务高级副总裁，扩展领导团队。
Oric Pharmaceuticals Expands Leadership Team With the Appointment of Keith Lui ...
08-06 04:15
ORIC Shares Rise After Announcing Prostate Cancer Drug Trial Collaborations
Unity Software(U.US) reported fourth-quarter financial results after the market...
07-17 07:08
